glp-1 for psoriasis agonists reduce severity and inflammation | JAMA Dermatology posted on the topic Psoriasis Patients Could Benefit From

Peptide therapy is generally not appropriate for patients who are pregnant, breastfeeding, have active hormone-sensitive cancers, or uncontrolled autoimmune conditions

Reduced hunger and smaller portions are early signs the medication is working, even before the scale catches up

In a meta-analysis with six studies (three liraglutide studies, three exenatide studies), treatment of GLP-1RAs produced significant improvements in liver histology such as lobular inflammation, hepatocellular ballooning, and fibrosis [78]

Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial

Beyond pituitary research, Hexarelin has drawn substantial scientific interest for cardioprotective signaling observed in preclinical models, activity reported to persist even when growth hormone receptor pathways are pharmacologically blocked